Rheumatoid arthritis, multiple sclerosis, psoriasis, Crohn’s disease

In his role as the Chief Operating Officer (COO) at Phenex Pharma , Professor Kleymann researches new agents and medications for the treatment of auto immune diseases such as rheumatoid arthritis, psoriasis, multiple sclerosis, Crohn’s disease, etc.

The innovative therapy approach via RORγ (ROR gamma) for modulation of the Th17 cell immune reaction is used.